Conventional treatment of interferon plus ribavirin limits the treatment of hepatitis C in some patients, so there are new drugs direct antiviral drugs (DAAs). Pros and cons of the latest…
Conventional treatment of interferon plus ribavirin limits the treatment of hepatitis C in some patients, so there are new drugs direct antiviral drugs (DAAs). Pros and cons of the latest…
Hepatitis C is one of the common viral hepatitis, hepatitis B, hepatitis C, and hepatitis D are 3 of the 5 viral hepatitis that are easy to slow down. Hepatitis…
Hepatitis C, or viral hepatitis C, is a relatively common infectious liver disease with serious consequences if left untreated. If actively treated, the vast majority of patients can achieve a…
Hepatitis C antibody, or anti-HCV, is a marker of viral infection in the body produced after infection with hepatitis C. Anti-HCV contains IgG and IgM, positive for both may be…
With the widespread use of the hepatitis B vaccine in children and the development of treatment technology, the number of hepatitis B infections in China has been gradually decreasing in…
The standard treatment regimen for patients infected with hepatitis C virus (all six genotypes) is pegylated interferon alpha-2a (Peg-interferon) in combination with ribavirin. Although sustained virologic response (SVR) is almost…
Hepatitis C Vaccine Hepatitis C virus is different from Hepatitis B virus, the former is an RNA virus, the latter is a DNA virus, the genome of the RNA virus…
Hepatitis C is an infectious disease that was only recognized in the late 1980s, caused by hepatitis C virus infection, mainly transmitted through blood, and its modes of transmission include:…
Hepatitis C is as dangerous as hepatitis B. Like hepatitis B, chronic hepatitis C is an important cause of cirrhosis and liver cancer. About 10 million people in China are…